Hannah Savage

Hannah Savage

Auto-generated profile, based on publicly available information

Hannah Savage

The University of Texas MD Anderson Cancer Center 1 Department of Pediatrics Research Houston, Texas

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2019 in Pediatric Blood & Cancer
Verified
Journal Article
Open access
PDF file
MMMiriam B. G. Morrell
Miriam B. G. Morrell
CAClaudia Alvarez‐Florez
Claudia Alvarez‐Florez
AZAiqian Zhang
Aiqian Zhang
EKEugenie S. Kleinerman
Eugenie S. Kleinerman
HSHannah Savage
Hannah Savage
KSKeri Schadler
Keri Schadler
Recent studies in mouse models of cancer have shown that exercise improves tumor vascular function, thereby improving chemotherapy delivery and efficacy. However, the mechanisms underlying this improvement remain unclear and the effect of exercise on Ewing sarcoma (ES), a pediatric bone and soft tissue cancer, is unknown. The effect of exercise on tumor vascular hyperpermeability, which inversely correlates with drug delivery to the tumor, has also not been evaluated. We hypothesized that exercise improves chemotherapy efficacy by enhancing its delivery through improving tumor vascular permeability. We treated ES‐bearing mice with doxorubicin with or without moderate treadmill exercise. Exercise did not significantly alter ES tumor vessel morphology. However, compared to control mice, tumors of exercised mice had significantly reduced hyperpermeability, significantly decreased hypoxia, and higher doxorubicin penetration. Compared to doxorubicin alone, doxorubicin plus exercise inhibited tumor growth more efficiently. We evaluated endothelial cell sphingosine‐1‐phosphate receptors 1 and 2 (S1PR1 and S1PR2) as potential mediators of the improved vascular permeability and increased function afforded by exercise. Relative to tumors from control mice, vessels in tumors from exercised mice had increased S1PR1 and decreased S1PR2 expression. Our results support a model in which exercise remodels ES vasculature to reduce vessel hyperpermeability, potentially via modulation of S1PR1 and S1PR2, thereby improving doxorubicin delivery and inhibiting tumor growth more than doxorubicin alone does. Our data suggest moderate aerobic exercise should be tested in clinical trials as a potentially useful adjuvant to standard chemotherapy for patients with ES.

12 June 2023 in Cancer Immunology Research
Verified
Journal Article
Closed access
PDF file
HSHannah Savage
Hannah Savage
SPSumedha Pareek
Sumedha Pareek
JLJonghae Lee
Jonghae Lee
Riccardo BallaròRiccardo Ballarò
Riccardo Ballarò
DMDarlan Conterno Minussi
Darlan Conterno Minussi
KSKeri Schadler
Keri Schadler
Exercise changes the tumor microenvironment by remodeling blood vessels and increasing infiltration by cytotoxic immune cells. The mechanisms driving these changes remain unclear. Herein, we demonstrate that exercise normalizes tumor vasculature and upregulates endothelial expression of VCAM1 in YUMMER 1.7 and B16F10 murine models of melanoma but differentially regulates tumor growth, hypoxia, and the immune response. We found that exercise suppressed tumor growth and increased CD8+ T-cell infiltration in YUMMER but not in B16F10 tumors. Single-cell RNA sequencing and flow cytometry revealed exercise modulated the number and phenotype of tumor-infiltrating CD8+ T cells and myeloid cells. Specifically, exercise caused a phenotypic shift in the tumor-associated macrophage population and increased the expression of MHC class II transcripts. We further demonstrated that ERK5 S496A knock-in mice, which are phosphorylation deficient at the S496 residue, “mimicked” the exercise effect when unexercised, yet when exercised, these mice displayed a reversal in the effect of exercise on tumor growth and macrophage polarization compared with wild-type mice. Taken together, our results reveal tumor-specific differences in the immune response to exercise and show that ERK5 signaling via the S496 residue plays a crucial role in exercise-induced tumor microenvironment changes. See related Spotlight by Betof Warner, p. 1158

10 January 2020 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
EMEnrica Marmonti
Enrica Marmonti
HSHannah Savage
Hannah Savage
AZAiqian Zhang
Aiqian Zhang
CBClaudia A.F. Bedoya
Claudia A.F. Bedoya
MMMiriam Garcia Morrell
Miriam Garcia Morrell
KSKeri Schadler
Keri Schadler

7 July 2026 in Cancer Research
Verified
Journal Article
Closed access
Riccardo BallaròRiccardo Ballarò
Riccardo Ballarò
TLTruong Lam
Truong Lam
SPSumedha Pareek
Sumedha Pareek
JLJonghae Lee
Jonghae Lee
HPHetal Patel
Hetal Patel
KSKeri Schadler
Keri Schadler
Pancreatic ductal adenocarcinoma (PDAC) is characterized by high resistance to anticancer therapies, which is caused in part by hypovascularization and dysfunctional vessels that inefficiently deliver chemotherapy. Exercise has been shown to improve tumor vascular function and chemotherapy efficacy in preclinical models. Uncovering the mechanism by which exercise modifies tumor vasculature could help identify potential strategies to improve drug delivery. In this study, we evaluated surgically resected PDAC from patients who exercised during neoadjuvant chemotherapy to demonstrate that exercise remodeled PDAC vasculature and improved tumor vascular function in patients. In mice bearing orthotopic PDAC and treadmill exercise, tumor vascular remodeling was dependent on sphingosine-1-phosphate receptor 1 (S1PR1) signaling in endothelial cells, and S1PR1 was necessary for improved chemotherapy efficacy by exercise. Exercise activated S1PR1 in tumor endothelium, improved tumor vascular function, and increased gemcitabine (Gem) delivery and efficacy. Mice with an endothelial cell–specific S1PR1 deletion did not display exercise-induced improvements in tumor vascular function or Gem efficacy. These findings demonstrate that exercise increases chemotherapy delivery and efficacy by improving vascular function, defining S1PR1 as a necessary mediator of exercise-induced vascular remodeling. Significance: Aerobic exercise induces tumor vasculature remodeling via endothelial S1PR1 to enhance drug delivery and suppress pancreatic cancer progression, supporting discovery of exercise efficacy biomarkers and therapeutic strategies for patients unable to exercise.

1 August 2015 in Microscopy and Microanalysis
Verified
Journal Article
Open access
PDF file
LYLinda S. Yasui
Linda S. Yasui
MJMegan Johnson
Megan Johnson
HSHannah Savage
Hannah Savage
ABAbraham Baker
Abraham Baker
EBElle Baker
Elle Baker
CBColton Burns
Colton Burns